BHVN

Biohaven Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 4/10
  • Momentum 2/10
Biohaven sales and earnings growth
BHVN Growth
Neutral
  • Revenue Y/Y 0.00%
  • EPS Y/Y 19.98%
  • FCF Y/Y -22.45%
Biohaven gross and profit margin trends
BHVN Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC -206.40%
Biohaven net debt vs free cash flow
BHVN Risk
Great
  • Debt / Equity -18.0
  • Debt / FCF 0.2
  • Interest coverage NA

Biohaven stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗